Evidence map›Paper›PMID 33739129›Full record

ArticleJournal of the American Heart Association2021

Association of Serum Testosterone and Luteinizing Hormone With Blood Pressure and Risk of Cardiovascular Disease in Middle-Aged and Elderly Men.

Mengyuan Qu, Chenzhao Feng, Xiaotong Wang, Yiqun Gu, Xuejun Shang, Yuanzhong Zhou, Chengliang Xiong, Honggang Li

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Review
  3. Observational
  4. Article
  5. Review
  6. Lotus seed (Journal of traditional and complementary medicine · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. New Horizons: Testosterone or Exercise for Cardiometabolic Health in Older Men.The Journal of clinical endocrinology and metabolism · 2023
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Mengyuan QuInstitute of Reproductive Health/Center of Reproductive Medicine Tongji Medical CollegeHuazhong University of Science and Technology Wuhan China.
Chenzhao FengSchool of Basic Medicine Tongji Medical CollegeHuazhong University of Science and Technology Wuhan China.
Xiaotong WangInstitute of Reproductive Health/Center of Reproductive Medicine Tongji Medical CollegeHuazhong University of Science and Technology Wuhan China.
Yiqun GuNational Research Institute for Family Planning Beijing China.
Xuejun ShangJinling Hospital School of Medicine Nanjing University Nanjing China.
Yuanzhong ZhouSchool of Public health Zunyi Medical University Zunyi China.
Chengliang XiongWuhan Tongji Reproductive Medicine Hospital Wuhan China.
Honggang LiInstitute of Reproductive Health/Center of Reproductive Medicine Tongji Medical CollegeHuazhong University of Science and Technology Wuhan China.
Huazhong University of Science and Technology · CNTongji Hospital · CNNanjing General Hospital of Nanjing Military Command · CNTianjin Municipal Research Institute for Family Planning · CNZunyi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The age-related decline in testosterone levels is thought to be of great importance for male aging and cardiovascular diseases. However, data are controversial on whether abnormal sex hormones are linked to the presence of cardiovascular diseases and it is also uncertain how blood pressure modifies the association between testosterone levels and major cardiovascular diseases. Methods and Results This is a multicenter, population-based, cross-sectional study of 6296 men conducted between 2013 and 2016. Basic information and clinical symptoms were obtained by questionnaires. Blood pressure and plasma levels of total testosterone, sex hormone-binding globulin, luteinizing hormone, and free testosterone were determined in men in a multistage random, cluster sampling in 6 provinces of China. There were 5786 Chinese men (mean [SD] age 55.0 [10.1] years) included after exclusion criteria were applied; 37.2% (2150) of them were diagnosed with hypertension. Total testosterone, free testosterone, and sex hormone-binding globulin were inversely associated with the prevalence of hypertension. Age >65 years or body mass index ≥24 negatively impacted the inverse correlation between testosterone levels and hypertension, whereas smoking and family history of hypertension strengthened the correlation. In participants with grade 2 hypertension, total testosterone was positively associated with the presence of stroke, and luteinizing hormone was also positively correlated with cardiovascular and cerebrovascular diseases. Conclusions Lower total testosterone could be a promising risk marker for prevalent hypertension. Both low and high levels of testosterone are associated with greater cardiovascular risk. Primary hypogonadism may be a risk marker for major cardiovascular diseases in men with severe hypertension.

Indexed as

AgedAge DistributionAge FactorsBiomarkersBlood PressureCardiovascular DiseasesChinaCross-Sectional StudiesHumansIncidenceLuteinizing HormoneMaleMiddle AgedPrevalenceRetrospective StudiesRisk FactorsBiomarkersLuteinizing HormoneTestosteronecardiovascular diseasehypertensionstroketestosterone

Identifiers

PMID33739129
PMCPMC8174322
OpenAlexW3139100890

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.